Solvias Research Team Receives Sandmeyer Award 2012

The Swiss Chemical Society has awarded the Sandmeyer Award 2012 to a research team from Solvias. Working for Sanofi Pasteur, the team developed an innovative, efficient and fully synthetic process for protoporphyrin IX, a precursor of hemoglobin.

The research team is made up of Dr. Dirk Spielvogel, Dr. Dietmar Flubacher, Dr. Andreas Boudier, Markus Müller and Dr. Pierre Martin from the Chemical Development and Catalysis department at Solvias.

Protoporphyrin IX is an essential co-factor in the biotechnological vaccine production process at Sanofi Pasteur. Changes to the law relating impurities of animal origin made it impossible to use this substance, which is extracted from blood. However, the researchers found an effective alternative in just a few months: they developed a fully synthetic means of access, which resulted - among other things - in the first substance samples for biotechnological process validation. Thanks to these efforts, the team entered new conceptual territory in the synthesis of porphyrins.

The award is sponsored by KPMG.

 

Company

Solvias AG

Im Römerpark 2
4303 Kaiseraugst
Switzerland

Company contact







Virtual Event

Digitalization in the Chemical Industry
CHEManager Spotlight

Digitalization in the Chemical Industry

Save the Date: October 22, 2025
The event will be promoted to a combined audience of over 100,000 professionals across Europe through the CHEManager and CITplus networks.

Interview

Specialty Chemicals in a Shifting World
Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.

most read

Photo
21.03.2025 • News

What’s Next for Pharma Supply Chains?

Sudden shifts in demand, supply shortages and global collapse have put immense pressure on pharmaceutical logistics. To address these challenges, PHARMAP 2025 brings together industry experts to discover AI-driven supply chain optimisation, strategic logistics partnerships and digital solutions that enhance efficiency and resilience in the pharmaceutical supply chain.